cbdMD, Inc. (YCBD) Operating margin 2016–2025
cbdMD, Inc. (YCBD) operating margin by fiscal year — reported operating income divided by reported revenue.
-11.3%FY2025 · since FY2016: -191.4% → -11.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.3% | +5.7 pp |
| FY2024 | -17.0% | +76.1 pp |
| FY2023 | -93.1% | +128.0 pp |
| FY2022 | -221.1% | -177.0 pp |
| FY2021 | -44.1% | -2.1 pp |
| FY2020 | -42.0% | +20.6 pp |
| FY2019 | -62.6% | +328.9 pp |
| FY2018 | -391.4% | -361.0 pp |
| FY2017 | -30.4% | +161.0 pp |
| FY2016 | -191.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More YCBD financial trends
YCBD RevenueYCBD Net incomeYCBD Net marginYCBD Gross profitYCBD Gross marginYCBD Operating incomeYCBD Operating cash flowYCBD Free cash flowYCBD Capital expendituresYCBD Return on equityYCBD Stock buybacksYCBD Dividends paidYCBD Total assetsYCBD Total liabilitiesYCBD Shareholders’ equityYCBD overview →